Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma

NCT02934204 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Primary CNS Lymphoma

Interventions

DRUG: methotrexate
DRUG: temozolomide

Sponsor

Guangdong Provincial People's Hospital